Figure 2.
Figure 2. Formation of high molecular weight complexes by BCR-ABL mutants. (A) Expression in Cos-1 cells was controlled by Western blot analysis using an α-ABL antibody. (B) Cos-1 cell lysates were fractionated by size-exclusion HPLC. The fractions indicated on the bottom were analyzed by Western blot using an α-ABL antibody. Molecular weights (MWs) corresponding to HPLC fractions are given on the top. Expression of the endogenous ABL and the transgenes is indicated by arrows.

Formation of high molecular weight complexes by BCR-ABL mutants. (A) Expression in Cos-1 cells was controlled by Western blot analysis using an α-ABL antibody. (B) Cos-1 cell lysates were fractionated by size-exclusion HPLC. The fractions indicated on the bottom were analyzed by Western blot using an α-ABL antibody. Molecular weights (MWs) corresponding to HPLC fractions are given on the top. Expression of the endogenous ABL and the transgenes is indicated by arrows.

Close Modal

or Create an Account

Close Modal
Close Modal